AOB KEIOH GROUP CORP has a total of 13 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2014. It filed its patents most often in Taiwan, Japan and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, foods and drinks and biotechnology are NUSIRT SCIENCES INC, SHIAO SHIN-JEN and INST BIOPHYTIS SAS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Taiwan | 4 | |
#2 | Japan | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | China | 2 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Foods | |
#4 | Microorganisms | |
#5 | Fodder | |
#6 | Microorganisms | |
#7 | Special foods |
# | Name | Total Patents |
---|---|---|
#1 | Takahashi Tomoya | 12 |
#2 | Nakano Hiroko | 4 |
#3 | Takayanagi Satoru | 4 |
#4 | Yasuda Takaaki | 4 |
#5 | Funayama Shinji | 4 |
#6 | Takano Fumihide | 4 |
#7 | Fushiya Shinji | 3 |
#8 | Pan I-Horng | 3 |
#9 | Wen Shu-Fang | 3 |
#10 | Yamamoto Kenji | 3 |
Publication | Filing date | Title |
---|---|---|
TWI689585B | Novel bacterial strain of lactobacillus and immunostimulant comprising the same | |
JP2020055578A | Manufacturing method of shrink-packaged article and shrink-packaged article | |
WO2018029793A1 | Il-6 production inhibitor, anti-inflammatory agent, anti-neurodegenerative disease agent, anti-neuropsychiatric disease agent, medicine and food | |
CN107708717A | Nerve cell apoptosis inhibitor, the agent of anti-Alzheimer disease, anti-Aging agent, the pharmaceuticals or the manufacture method of food and nerve cell apoptosis inhibitor with the effect of anti-Alzheimer disease or the effect of anti-Aging | |
JP2015164901A | Hyaluronic acid synthesis promotor, has2 mrna expression promotor, pharmaceutical, food product or cosmetic having hyaluronic acid synthesis promoting action, and pharmaceutical, food product or cosmetic having has2 mrna expression promoting action |